Methods: Mast cells were differentiated from human cord blood-derived CD34+ progenitor cells in vitro (CBMC), and their expression of scavenger receptors was analyzed by conventional RT-PCR, flow cytometry and Western blot techniques. Fluorescently-labeled oxLDL was used to investigate LDL internalization by mast cells. Secretion of pro-inflammatory cytokines into the incubation medium and degranulation of the mast cells in response to oxLDL were assayed by ELISA and a colorimetric-enzymatic test for beta-hexosaminidase, respectively.
Results: CBMC expressed mRNA and protein for LOX-1, SR-AI and CD68, but not for CD36, and the expression of LOX-1 and SR-AI was upregulated by incubation of the cells with oxLDL. CBMC internalized oxLDL more efficiently than native LDL, while simultaneous neutralization of CD68, SR-AI and LOX-1 with monoclonal antibodies resulted in reduced oxLDL uptake. Moreover, in response to oxLDL, CBMC showed increased release of β-hexosaminidase, and a dose-dependent secretion of the pro-inflammatory cytokines IL-8 and MCP-1.
Conclusion: Our results reveal that cultured human mast cells express scavenger receptors that are up-regulated by oxLDL. In atherosclerotic lesions, oxLDL may activate MC to secrete pro-inflammatory cytokines, and so they cause mast cells to act as a cellular link between oxLDL and the inflammatory response in atherosclerosis.